Access cutting-edge kidney cancer treatment through this clinical trial at a research site in Oak Park. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Oak Park location
Access kidney cancer specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related kidney cancer treatment provided free
Check if you qualify for this kidney cancer clinical trial in Oak Park, IL
No-Cost Study Care
Local to Oak Park
Convenient for IL residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This phase II trial studies whether adding radium-223 dichloride to the usual treatment, cabozantinib, improves outcomes in patients with renal cell cancer that has spread to the bone. Radioactive drugs such as radium-223 dichloride may directly target radiation to cancer cells and minimize harm to normal cells. Cabozantinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Giving radium-223 dichloride and cabozantinib may help lessen the pain and sympto
Sponsor: National Cancer Institute (NCI)
Yes, this clinical trial (NCT04071223) has an active research site in Oak Park, IL that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for kidney cancer treatment options in Oak Park, IL, this clinical trial (NCT04071223) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Oak Park research site is actively enrolling participants for this clinical trial. You'll receive care from experienced kidney cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all kidney cancer clinical trials near you to find additional studies recruiting in your area.
See all kidney cancer clinical trials recruiting in Oak Park — not just this study.
Browse Kidney Cancer Trials in Oak Park →